title: Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005.
authors.forename: Neil
authors.initials: N
authors.lastname: Poulter
authors.forename: Alan D
authors.initials: AD
authors.lastname: Hughes
authors.forename: Bryan
authors.initials: B
authors.lastname: Williams
authors.forename: Adrian J B
authors.initials: AJ
authors.lastname: Brady
authors.forename: Gordon
authors.initials: G
authors.lastname: McInnes
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003920:Diabetes Mellitus / Q000188:drug therapy; D006331:Heart Diseases / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects; D012084:Renin-Angiotensin System / Q000187:drug effects*; D012955:Societies, Medical; D020521:Stroke / Q000517:prevention & control; D006113:United Kingdom
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors